EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Placental lesions induced by Omicron SARS-CoV-2 in a pregnant woman treated with anti-CD20

C Dubucs, N Dupuis, A Jourdes, P Delobel, C Auzet, N Van Acker, C Pasquier, J Aziza

Placenta · 2025

DOI: 10.1016/j.placenta.2025.03.015 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Placenta, 2025. Verfasst von C Dubucs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytology and Pathology, IUCT Oncopole, Toulouse, France. Electronic address: dubucs.charlotte@iuct-oncopole.fr. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Pregnancy Complications, Infectious, Placenta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the emergence of SARS-CoV-2 in 2020, specific placental lesions characterized by a triad of trophoblastic necrosis, chronic histiocytic intervillitis, and massive perivillous fibrin deposits have been documented during pregnancy. After the arrival of the Omicron variant in late 2021, no placental lesions were observed at our institution until a recent case in September 2024 involving an immunosuppressed patient treated with anti-CD20. In this case, pathological analysis revealed the classic lesion triad, with strong immunohistochemical positivity for SARS-CoV-2. This suggests that placental tropism persists in certain variants several years after the emergence of SARS-CoV-2, necessitating vigilance in monitoring potential complications, especially in immunocompromised patients, regardless of variant classification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Pregnancy Complications, InfectiousPlacentaPlacenta DiseasesHumansFemalePregnancyAdultImmunocompromised Host

Stichwörter der Autor:innen

Anti-CD20COVID-19Chronic histiocytic intervillitisHistologyMassive perivillous fibrin depositsOmicronPlacentaPregnancySARS-CoV-2Trophoblastic necrosis

Autor:innen und Institutionen

  • Department of Cytology and Pathology, IUCT Oncopole, Toulouse, France. Electronic address: dubucs.charlotte@iuct-oncopole.fr.
  • Department of Gynecology and Obstetrics, Paule de Viguier Maternity Hospital, CHU de Toulouse, Toulouse, France.
  • Infectious Disease Unit, CHU Toulouse, Toulouse, France.
  • Peadiatric Unit, CHU Toulouse, Toulouse, France.
  • Imag'IN Platform, Department of Cytology and Pathology, CHU, IUCT Oncopole, Toulouse, France.
  • Virology Department, Federal Institute of Biology, CHU de Toulouse, Toulouse, France.

Zitieren

APA

Dubucs, C., Dupuis, N., Jourdes, A., Delobel, P., Auzet, C., Van Acker, N., Pasquier, C., & Aziza, J. (2025). Placental lesions induced by Omicron SARS-CoV-2 in a pregnant woman treated with anti-CD20. Placenta. https://doi.org/10.1016/j.placenta.2025.03.015

Vancouver

Dubucs C, Dupuis N, Jourdes A, Delobel P, Auzet C, Van Acker N, et al. Placental lesions induced by Omicron SARS-CoV-2 in a pregnant woman treated with anti-CD20. Placenta. 2025. doi:10.1016/j.placenta.2025.03.015

BibTeX
@article{Dubucs2025,
  author = {Dubucs, C and Dupuis, N and Jourdes, A and Delobel, P and Auzet, C and Van Acker, N and Pasquier, C and Aziza, J},
  title = {Placental lesions induced by Omicron SARS-CoV-2 in a pregnant woman treated with anti-CD20},
  journal = {Placenta},
  year = {2025},
  doi = {10.1016/j.placenta.2025.03.015}
}
Kostenlos starten →